K172913

Substantially Equivalent

cobas Factor II and Factor V Test

Applicant: Roche Molecular Systems, Inc.
Product code: NPR
Advisory panel: Hematology
Date received: 2017-09-25
Decision date: 2018-01-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Pleasanton, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.